Abstract
Acoustically detecting the optical absorption contrast, photoacoustic imaging (PAI) is a highly versatile imaging modality that can provide anatomical, functional, molecular, and metabolic information of biological tissues. PAI is highly scalable and can probe the same biological process at various length scales ranging from single cells (microscopic) to the whole organ (macroscopic). Using hemoglobin as the endogenous contrast, PAI is capable of label-free imaging of blood vessels in the brain and mapping hemodynamic functions such as blood oxygenation and blood flow. These imaging merits make PAI a great tool for studying ischemic stroke, particularly for probing into hemodynamic changes and impaired cerebral blood perfusion as a consequence of stroke. In this narrative review, we aim to summarize the scientific progresses in the past decade by using PAI to monitor cerebral blood vessel impairment and restoration after ischemic stroke, mostly in the preclinical setting. We also outline and discuss the major technological barriers and challenges that need to be overcome so that PAI can play a more significant role in preclinical stroke research, and more importantly, accelerate its translation to be a useful clinical diagnosis and management tool for human strokes.
Introduction
Ischemic stroke occurs with a vessel blockage of blood flow in a certain region of the brain. This blood flow interruption is often a result of embolic or thrombotic occlusion of an artery within the brain. The interruption of blood flow in the brain can cause tissue damage, such as neuronal injury and death, due to a lack of vital nutrient delivery to the brain tissue. Thus, timely detection and removal of the blood clot and recanalization of the vessel are critical for acute ischemic stroke treatment (). The first-line acute stroke treatment is mechanical or pharmacologic reperfusion therapy (), and use of a clinical imaging modality such as magnetic resonance angiography (MRA) or computed tomography angiography (CTA) that can visualize the occluded vessel. These imaging modalities come at a high cost and require the use of exogenous contrast agents. Furthermore, these clinical modalities often provide only the information of blood perfusion, but lack the ability to measure blood oxygenation, the presence of specific biomolecules, or tissue viability. Thus, MRA and CTA are less used in preclinical studies of ischemic stroke. Instead, preclinical studies of ischemic stroke have heavily relied on the use of histology and behavioral testing as measures of experimental treatment efficacy. However, histology requires sacrifice of the animals and thus can only be used as an endpoint measure, and behavioral tests cannot provide concrete anatomical or physiological information. To provide a more efficient and quantitative approach to measuring stroke outcomes, various biomedical imaging technologies have recently been developed and tested for preclinical ischemic stroke studies.
Photoacoustic imaging (PAI) has emerged as a popular biomedical imaging modality over the past twenty years due to its intrinsic ability to combine optical contrast with acoustic detection (; ). The fundamental imaging principle of PAI is shown in Figure 1. A short laser pulse excites the sample, leading to the absorbers within the target to heat up via photothermal effect. This temperature rise results in a thermoelastic expansion and subsequently outwardly propagating ultrasound waves. In principle, any molecule absorbing light qualifies as a potential contrast in PAI, allowing for a plethora of both endogenous and exogenous contrast agents (). Of the endogenous category, hemoglobin is the most commonly used contrast for PAI due to its abundance in biological tissues and its relatively strong optical absorption in the visible and near-infrared (NIR) light domain. With hemoglobin used as the primary contrast, PAI has been widely used as an angiographic imaging modality that produces blood vessel images in the deep tissues. While the spatial scale of PAI varies greatly from microscopic to macroscopic depending on the implementation, the contrast origin remains the same at all scales. This makes PAI a powerful research tool to investigate the same biological phenomena at vastly different scales.
FIGURE 1
Photoacoustic imaging (PAI) has two major implementations: photoacoustic microscopy (PAM) and photoacoustic computed tomography (PACT) (). PAM can be further divided into optical-resolution PAM (OR-PAM) and acoustic-resolution PAM (AR-PAM). OR-PAM differentiates itself from AR-PAM based on the tight optical focusing of the excitation light. AR-PAM relies on diffuse optical excitation, while the resolution depends on the acoustic focusing of the ultrasound transducer. OR-PAM produces higher resolution images than AR-PAM but has a superficial penetration depth (∼1 mm). The macroscopic PAI implementation, PACT, utilizes diffuse light excitation and parallel acoustic detection with ultrasound transducer arrays to create tomographic images. PACT generally has a greater penetration depth (>1 cm) than PAM implementations, but lower spatial resolution (>300 μm).
Due to the high flexibility of ultrasound transducers and methods of diffuse light illumination, PACT has many different implementations. The geometry of the transducer elements, scanning pattern, central frequency and bandwidth, excitation laser wavelength and delivery method, and reconstruction technique all contribute to the resultant image quality. Depending on the design requirements of the imaging system, an optimal combination of system components can be selected. For example, while a hemispherical ultrasound transducer can produce higher spatial-resolution with minimal limited-view artifacts, it usually provides a smaller field of view than a planar or ring-shaped array with the same number of elements (). Furthermore, choosing a high-frequency transducer will result in high resolution images at the cost of imaging depth and increased sensitivity to the speed of sound heterogeneity. The experimental challenges of acquiring data should also be considered when designing a PACT system. For example, brain imaging with a full-ring array can be more experimentally difficult than with a hemispherical or linear-array due to the need for acoustic coupling between the head and transducer. The PACT implementation for preclinical stroke study can be optimized by considering the desired spatial and temporal resolution, field of view, detection sensitivity, cost, and animal models.
While PAI has been used in several applications in brain research (), imaging acute ischemic stroke is of particular interest, due to both the blood-sensitive nature of PAI and the severity and prevalence of ischemic stroke (). Over 795,000 people per year in the US suffer stroke, approximately 80% of which are ischemic stroke (). Stroke remains a leading cause of disability in the US, including language difficulty and cognitive deficits, with motor impairment being the most common complication after stroke. Many stroke survivors struggle with daily activity and have poor quality of life.
With its ability to provide both structural and functional information of the brain vessels, PAI can be a useful imaging tool in the setting of ischemic stroke. Ischemic stroke causes disrupted blood flow to a region of the brain, resulting in reduced vessel density and blood oxygenation, both of which can be readily detected by using PAI at different length scales without using any exogenous contrast agents (). Thus, PAI of ischemic stroke has been extensively investigated and validated (; ; ; ; ). Using PAI as an alternative to MRA or CTA in evaluating post-stroke reperfusion could provide many benefits for the patients, although there are significant technical obstacles that need to be overcome.
This concise review is divided into two major sections. In the first section, we introduce the current achievements of PAI in ischemic stroke study at multiple length scales, ranging from micro vessels in small animal brains to major vessels in human brains. In the second section, we discuss the major technological challenges still faced in PAI of ischemic stroke, both in light and sound, and we present potential solutions that may translate PAI into a more powerful technology for neuroscience research.
Applications of photoacoustic imaging in preclinical ischemic stroke research
The works presented in this review were mostly identified using the Google Scholar search engine by November 2022. The major key words used in the search engine included ischemic stroke, photoacoustic imaging, photoacoustic microscopy, photoacoustic computed tomography, and brain imaging. Over 300 papers were reviewed, wherein the relevance, novelty, and quality of the imaging systems were the main criteria when considering representative papers for inclusion.
Representative applications of PAI in ischemic stroke research in the last decade is summarized in Table 1. The included papers were chosen to represent ischemic stroke studies from single-vessel to large-animals, showing the wide range of imaging scales of PAI. Among these studies, three stroke models have been used in PAI studies: photothrombotic (PT) stroke, temporary and permanent middle cerebral artery occlusion (tMCAO and pMCAO) (; ). PT and pMCAO stroke models represent permanent ischemic stroke injury while the tMCAO model represents ischemic stroke with reperfusion.
TABLE 1
| Authors | System | Resolution (lateral × axial) | Penetration | Optical wavelength | U/S detection | Stroke model | Animal model | Year |
| OR-PAM | ∼10 μm | ∼1 mm | 532/558 nm | 40 MHz 100% bandwidth focused transducer | pMCAO | Mouse | 2022 | |
| OR-PAM | ∼24 × 45 μm | ∼1 mm | 720 nm | 50 MHz cylindrical transducer | PT | Rat | 2022 | |
| PACT | <1 mm | ∼5 mm | 700–900 nm in 10 nm intervals | 128 element 5.2 MHz linear array | PT | Neonatal piglet | 2022 | |
| PACT | ∼200 μm | ∼5 mm | 680/750/850 nm | 128 element 5 MHz hemispherical array | PT/pMCAO | Mouse | 2019 | |
| OR-PAM | <100 μm | ∼1 mm | 532/558 nm | 35 MHz 70% bandwidth focused transducer | tMCAO | Mouse | 2018 | |
| OR-PAM | ∼3 × 15 μm | ∼1 mm | 532 nm | 50 MHz 100% bandwidth cylindrical transducer | PT | Mouse | 2016 | |
| AR-PAM | ∼45 × 15 μm | >1 mm | 576/584/592 nm | 50 MHz 70% bandwidth focused transducer | pMCAO | Rat | 2012 | |
| OR-PAM | <100 μm | ∼1 mm | 563/570 nm | Cylindrical transducer | pMCAO | Mouse | 2011 |
Summary of major publications on ischemic stroke using PAI in the past decade.
PT, photothrombotic; pMCAO, permanent middle cerebral artery occlusion; tMCAO, temporary middle cerebral artery occlusion.
Imaging mini-stroke at single-vessel level
Taking advantage of the high spatial resolution of PAI, especially PAM, researchers have been able to investigate occlusion of a small vessel within the brain. For example, used both PAM and PACT to visualize single-vessel ischemic stroke using a PT stroke model in rats, as shown in Figure 2A. The PT stroke model uses a laser beam to activate a photoactive dye (e.g., Rose Bengal) and cause coagulation restricted to the illuminated region, allowing for a small beam to produce a targeted single-vessel occlusion in vivo. Both PA modalities were used to evaluate the performance of an experimental ischemic stroke treatment. The treatment was a photothermal-activatable liposome carrying tissue plasminogen activator (tPA), which once activated (by laser irradiation) could dissolve a blood clot and induce recanalization. The PA imaging was performed before and after stroke, and after tPA treatment, showing the healthy flow, impaired flow, and restored flow, respectively. This study displayed the feasibility of both PAM and PACT for ischemic stroke treatment monitoring, an exciting application of the imaging technology.
FIGURE 2
In another study, applied high-speed PAM to monitor the occurrence of mini-stroke at the capillary level in mouse models. Using a microelectromechanical system (MEMS) scanning mirror in conjunction with a high pulse repetition rate laser, they were able to image microvasculature at high spatial resolution (∼3 μm lateral and ∼15 μm axial) and high temporal resolution (400 Hz B-scan rate over 3 mm scanning range). They were able to observe the occlusion location and to measure the changes in microvascular blood flow resulting from the photothrombosis. Interestingly, their data demonstrated a vastly reduced blood flow velocity in the parent vessel, with a reversed blood flow in one of the branching daughter vessels, as shown in Figure 2B.
Multi-scale imaging of ischemic stroke on small-animal models
Small model animals, such as mice and rats, are commonly used in PAI technological development and biomedical applications. PAI is well suited for small-animal imaging of ischemic stroke because of the relatively thin skull, which is one of the predominant difficulties of PA and ultrasound-based brain imaging. Although not negligible, the relatively thin skull can partially mitigate the acoustic aberration and optical scattering (; ). This is beneficial for achieving high imaging quality by OR-PAM (; ), AR-PAM (; ), and PACT (; ) of mouse and rat brains. OR-PAM can produce the high-resolution (a few micrometers) images of ischemic stroke, such as Figure 3A. However, OR-PAM often requires removing the scalp, thinning the skull, or sometimes even installing a cranial window, which makes the modality invasive and more difficult for longitudinal studies of ischemic stroke on the same animals. OR-PAM also has superficial penetration depth (∼1 mm), since it relies primarily on the tight focusing of ballistic photons, which is undesirable for ischemic stroke studies because the injured tissue is generally not constrained to the superficial regions of the brain. On the other hand, AR-PAM utilizes diffuse photons while maintaining relatively tight acoustic focusing. This allows for improved penetration depth to ∼3-5 mm at the cost of spatial resolution (tens of micrometers) relative to OR-PAM. Figure 3B shows representative images of pre and post ischemic stroke utilizing and AR-PAM system. Of the three major implementations of PAI, PACT is the most promising for studying ischemic stroke on the whole-brain level in small-animal models, with a spatial resolution of a few hundred micrometers. Both and we used PACT to visualize PT stroke in mice both structurally and functionally (Figure 3C). Many small-animal PAI studies have allowed better understanding of the neuroprotective processes and hemodynamics that occur in response to ischemic stroke (; , ; ; ), and the ability to assess potential treatments for ischemic stroke (; ).
FIGURE 3
Deep imaging of ischemic stroke on large-animal models
Photoacoustic imaging (PAI) has been successfully applied for both ex vivo and in vivo studies of ischemic stroke on large animal models. Large animal models better simulate the conditions of human brains, namely the size of the brain and thickness of the skull. Therefore, the application of PAI of ischemic stroke on large animals is a prerequisite to human stroke research. Hariri et al. tested the feasibility of transfontanelle PAI using an ex vivo sheep brain, with an opening in the skull mimicking the fontanelle (). The results showed that functional PAI through the fontanelle of a neonate brain is possible. Later, Kang et al. similarly showed the feasibility of neonatal functional PAI using an in vivo pig model (). In a follow-up study, as shown in Figure 4, used a linear-array transducer to image neonatal pigs within 2 h following a PT stroke surgery. They found significant changes in both blood perfusion and oxygenation between injured and non-injured regions of the brain, demonstrating that PAI can be used for detecting perinatal ischemic stroke. Perinatal ischemic stroke occurs in 1 in 2300 term infants, which is 17 times more common than later in childhood or beyond (), and is a particularly compelling and clinically relevant application for PAI. The relatively small head size, the thinner bone, and the soft fontanelles of infants all help PAI achieve higher spatial resolution and larger penetration depth. These recent advances in PAI of ischemic stroke in large-animal models show a promising trend of technology advancement. Nevertheless, far fewer large-animal studies exist than small-animal studies so far, mostly due to the experimental difficulty and technology limitation. As a prerequisite to human stroke studies using PAI, more large-animal studies must be performed for extensive validation.
FIGURE 4
Clinical translation of photoacoustic imaging for human brain imaging
Ultimately PAI can be developed for use in human brain imaging, but there are several technical challenges for example, strong acoustic aberration of the thick human skull (∼6–8 mm) and the strong optical attenuation. There have been no published reports utilizing PAI to monitor ischemic stroke in humans yet. simulated the acoustic distortion caused by the human skull using different implementations of PACT. They found that the reflections, refractions, and mode-conversions of the human skull can introduce severe signal distortion and reconstruction artifacts in PACT, greatly reducing the resolution and quantitative accuracy of the image reconstructions. As shown in Figure 5, Na et al. imaged hemicraniectomy patients using MRA and PACT (). The results showed that the MRA and PACT can provide well-matched structural images of the human brain vasculature at depths up to 10 mm under the cortical surface. Functional MRI (fMRI) and functional PACT were also performed to monitor the brain activities in the motor and language regions in response to certain activities, such as finger tapping and passive listening. Although it has not been applied for monitoring ischemic stroke on humans yet, this recent study demonstrated that high-quality human brain imaging can be achieved with PAI technology.
FIGURE 5
Technological challenges and solutions for photoacoustic imaging
All the above achievements in PAI of ischemic stroke have reflected the strong momentum of this exciting technology and its great potential in preclinical stroke research. However, to maximize its impact, there are still major technical challenges in PAI that need to be addressed through innovative solutions in laser engineering, data science, mathematics, and chemistry. These challenges can be broadly divided into two categories: optical challenges and acoustic challenges, as summarized in Figure 6.
FIGURE 6
Optical challenges
Limited penetration depth of light due to strong optical attenuation
Skin, bone, and brain tissue are three of the most scattering biological tissues in the 500-900 nm optical wavelength range (), making light penetration deep into the brain (>1 cm depth) a difficult task. To avoid tissue damage, there exist limitations on the maximum optical energy density that can be delivered to the surface of the skin, usually guided by the laser safety standard by the American National Standards Institute (ANSI). Thus, simply increasing the excitation light energy is not a preferred option for PAI to improve its penetration depth. A few engineering solutions have been developed to improve optical penetration depth while maintaining the laser safety.
Table 2 summarizes reported illumination techniques for improving penetration depth in PAI of brains. One solution is the use of internal illumination in PAI. Laser pulses delivered within the body cavity, generally via catheter or miniaturized probe, bypass the highly absorbing layers of skin and bone, and thus can often be closer to the target being imaged. Internal illumination PAI has shown great promise for improving optical penetration depth in the animal brains through phantom experiments and in vivo imaging, by delivering light through the oral cavity (; ). In a different approach, improved optical penetration depth by increasing the efficiency of light delivery using a photon recycler. The photon recycler was a highly reflective surface which re-delivered photons that had been scattered out of the skin surface back into the brain. Wavefront engineering is another potential solution for improving optical penetration depth while maintaining high resolution. This allows focusing light into a deeper region of a scattering medium (; ). Optimizing the excitation wavelength can further improve optical penetration depth in PAI. For example, Xu et al. used microwave excitation to image a whole Rhesus monkey brain (). However, it should be noted that changing the excitation wavelength may change the source of contrast to other biomolecules such as water.
TABLE 2
| References | Method | Reported depth | Excitation wavelength | Target | Year |
| Multi-angle illumination | ∼2.5 cm | 750 nm | Ex vivo sheep brain | 2022 | |
| Dual illumination | ∼3 cm | 680 nm | Cervical tissue phantom | 2020 | |
| Internal illumination | ∼5 cm | 1064 nm | In vivo mouse heart | 2018 | |
| Photon recycler | 1–2 cm | 1064 nm | Ex vivo canine brain | 2012 | |
| Microwave excitation | ∼3 cm | 1.5 cm | Ex vivo rhesus monkey brain | 2006 |
Summary of illumination techniques for improving penetration depth in PAI of brains.
Limited optical contrast of brain functions
In the NIR excitation domain, lipids, hemoglobin, melanin, and water are the primary endogenous sources of PAI contrast (). While hemoglobin can be used to probe the brain’s hemodynamics, these exogenous contrasts fall short of providing more information about the brain’s functional and molecular status, such as the neuroactivities and inflammation. Ultimately, ischemic stroke causes critical damage to the neurons in the infarct region. To precisely quantify the effect and severity of stroke, the health and function of the neurons must be evaluated, which cannot be achieved by measuring blood oxygenation alone. Many exogenous PAI contrast agents have been developed in order to resolve this issue (; ; ; ). Exogenous contrast agents often have stronger optical absorption and thus provide stronger PA signals and larger penetration, as well as target certain physiological events, particularly neuronal activities (; ). In an exciting example, , using an engineered NIR genetically encoded calcium indicator, simultaneously imaged hemodynamics and neuronal activity in mouse brains with PAM and fluorescence microscopy. Such targeted contrast provides a powerful new pathway for photoacoustic signal generation in the brain and can also be applied to provide more comprehensive information of the brain impaired by ischemic stroke ().
Inaccurate quantitative analysis due to wavelength-dependent light attenuation
Functional PAI often requires multiple excitation wavelengths to spectrally unmix the concentrations of several absorbing molecules that collectively contribute to the PA signals. Assuming a total of n molecules contributed to the PA signals, linear unmixing methods require at least a total of n images to be taken at different wavelengths, in order to solve a system of linearly independent equations with n unknowns. However, this commonly used linear model assumes an important oversimplification: the optical fluence at a given depth in a target strongly depends on the wavelength of light used to illuminate the target (). This is inherently due to the wavelength-dependent optical absorption and scattering coefficients of biological tissue. Therefore, linear unmixing cannot produce accurate quantification of molecular concentrations in deep tissues. Alternatively, measurements of relative quantities can still be made and produce informative results. For example, Matsumoto et al. distinguished between arteries and veins by comparing deoxygenated blood in veins to nearby oxygenated blood in arteries ().
Although wavelength-dependent optical fluence is a pervasive problem for functional PAI, more accurate solutions do exist. Using PAI as a functionally complementary modality to MRI or computed tomography (CT) could allow for fluence-correction by simulating photon transport in tissues, using the anatomical information from MRI and CT (; ). Furthermore, iterative (or model-based) reconstruction methods, such as the algorithm proposed by , can map both the optical fluence and speed of sound in the heterogeneous media (; ; ), allowing for more accurate image reconstruction and spectral unmixing.
Acoustic challenges
Strong acoustic impact of the skull
Reflection, refraction, and mode conversion of acoustic waves occur at boundaries of brain tissue and skull with drastically different acoustic impedance, resulting in signal loss of upward of 75% (), which is related to the density and speed of sound of the medium (). In ultrasound imaging, reflection is desirable during the forward propagation of the acoustic waves because it provides the image contrast. In photoacoustic imaging, however, reflection of acoustic waves is normally undesirable; the reflections reduce signal strength and introduce artifacts in the image reconstruction (; ; ). The refraction of photoacoustic waves propagating from the target to the transducer result in distortions in the reconstructed image, primarily because most reconstruction algorithms, such as the ubiquitous delay and sum (DAS) method, assume linear ultrasound transmission in a homogeneous medium (). Furthermore, ultrasound propagation through the skull results in significant shear waves due to mode conversion, leading to further distortions in image reconstruction ().
The most practical method for reducing the impact of the skull in PAI is to use low-frequency detection. Lower ultrasonic frequencies show less attenuation and thus greater penetration than higher frequencies, allowing for more signal to bypass the skull with less distortion. However, the use of lower frequencies also results in a reduction of spatial resolution. Co-registered anatomical information, such as from MRI or CT, could similarly improve PA reconstructions by providing segmented skull geometry (). This would allow the reconstruction (e.g., time reversal method) to correct for acoustic absorption, refraction, and speed-of-sound inhomogeneities between tissue layers. Skull clearing cranial windows have also shown promise in small-animal PAI to reduce both the optical and ultrasonic attenuation, improving the overall vascular brain images (; ). However, these are invasive procedures, limiting their use to preclinical studies.
Incomplete target structure due to limited detection view
An exact reconstruction of the initial pressure distribution in PAI requires a detector that can completely surround the object being imaged, or provide a detection view of 4π. In practice, this is very challenging to implement, leading to the well-known limited-view problem in PAI that manifests as incomplete structure and reconstruction artifacts (). The limited-view problem is augmented in brain imaging due to the size and shape of the head, adding distortions and artifacts to the image reconstruction. Deep-learning and model-based approaches have been applied to reduce the limited-view artifacts (; ; ; ; ). demonstrated the use of a generative adversarial network to reduce the limited-view artifacts using simulated, phantom, and in vivo data. This approach allows for the reduction of the limited-view artifacts without changing the imaging system design. Even so, enlarging the detection geometry is the most effective way to mitigate the limited-view problem. For example, a 2D ring detection geometry or a hemispherical detection geometry are reported to produce superior whole-brain imaging, due to larger detection angles (). However, using these detection arrays can introduce a higher cost of the system and also require a more complicated experimental setup. Alternatively, multiple acquisitions could be acquired at varying angles and later integrated during the image reconstruction, which, however, may result in a decreased temporal resolution and thus increased susceptibility to motion artifacts. This approach was used by Zhang et al. to image a whole mouse brain using a linear-array, in which 39 limited-view images were combined to create an enhanced image (). A new approach for bypassing the limited-view problem is to track sparsely distributed highly absorbing exogenous contrast as point targets as they flow through the blood vessels, though this method results in a longer scanning time as a large number of frames are needed to accumulate sufficient contrast agents in the field of view ().
Limited spatial resolution due to the band-limited ultrasound detection
Photoacoustic signals have an inherently broad bandwidth and are highly related to the target sizes, ranging from below 1 MHz to over tens of MHz (). In most PAI systems, piezo-based ultrasound transducers used in traditional ultrasound imaging are adapted as the acoustic sensor, usually due to the broad availability and convenience. However, piezo-based ultrasound transducers are not optimized to sense photoacoustic signals as the elements often have both narrow acceptance angles and narrow bandwidths. Photoacoustic imaging systems require ultrasound sensing that is more suited to the broad-band nature of a photoacoustic signal ().
An emerging solution is optical acoustic sensors for PAI, including amplitude-modulation-based and interferometer-based sensors. A number of studies have shown the optical acoustic sensors can usually achieve higher detection sensitives per unit sensor area, broader detection bandwidths, and larger acceptance angles, compared with traditional piezoelectric sensors (; ; ). Although optical sensors show great promise, they are mostly used as a single-element detector for either PAM or PACT (), which has substantially limited imaging speed. Arrays of these sensors are necessary for fast PACT, but they are often difficult to fabricate with high uniformity, particularly of the resonant frequencies (). Furthermore, resonance-based optical sensors tend to be unstable due to thermally induced resonant-frequency shifts. Improving the stability and fabrication process for optical sensors will be an enormous step forward for the field.
Conclusion and discussion
The blood-sensitive nature of PAI makes it well suited for investigating ischemic stroke. By combining rich optical contrast with deep ultrasonic detection, PAI can be a safe alternative or complement to existing imaging modalities for studying vasculature. Furthermore, with high spatial scalability and tunable optical contrast, PAI allows for both microscopic imaging at single blood vessel level and macroscopic imaging at tissue level, providing ample metrics to monitoring ischemic stroke disease progress in timely fashion.
PAI is already a proven tool in preclinical ischemic stroke studies, particularly in small-animal stroke models. Both PAM and PACT have been used to investigate the hemodynamic processes in ischemic stroke (major publications shown in Table 1). The ability to monitor the vasculature and hemodynamics in small animals both non-invasively and longitudinally allows precise evaluation of the safety and efficacy of new treatments. As PAI technology continues to improve, more groundbreaking discoveries of the pathophysiological processes in ischemic stroke are expected in the near future.
The advancement of PAI technology in the past decade has allowed the technology to be more widely applied in imaging ischemic stroke. PAM technology has seen improvement in imaging speed, field-of-view, resolution, and sensitivity (). These improvements have come from the application of novel high-speed multi-spectra light sources (, ; ), deep learning imaging enhancement (, ), innovative scanning configurations (), and exogenous contrast agents (). These developments have allowed for better quantification and visualization of the hemodynamics of ischemic stroke. PACT technology has also improved in image reconstruction algorithms (), depth of penetration, imaging speed, and resolution (). These advances have culminated in recent years to the use of PACT in brain imaging in large animal models and, for the first time, in humans. As PAI technology continues to develop in the coming decade, PAI-enabled advances in the understanding and treatment of ischemic stroke are expected to follow.
Although PAI has many existing clinical applications (), clinical use of the technology for ischemic stroke treatment guidance and reperfusion assessment is yet to be explored. Robust solutions to the technological challenges presented in human brain imaging are a prerequisite for establishing PAI as a practical clinical tool. Promising technological advances have already been reported in attempts to solve the current problems, including the development of PA contrast agents and optical ultrasound sensors, the use of model-based image reconstructions and deep learning image enhancement, and innovative detection and illumination schemes. More rigorous evaluations of the PAI technologies on large animal stroke models are necessary before moving on to human testing.
Statements
Author contributions
JY and LM conceived the project and wrote the manuscript. All authors reviewed and edited the manuscript.
Funding
This work was sponsored by National Institutes of Health (R01 EB028143, R01 NS111039, RF1 NS115581, R21 EB027304, R21 EB027981, and R01 EB031629), National Science Foundation CAREER Award (2144788), and Chan Zuckerberg Initiative Grant on Deep Tissue Imaging 2020-226178 by Silicon Valley Community Foundation.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AldrichJ. E. (2007). Basic physics of ultrasound imaging.Crit. Care Med.35S131–S137. 10.1097/01.CCM.0000260624.99430.22
2
BasijM.KarpioukA.WinerI.EmelianovS.MehrmohammadiM. (2021). Dual-illumination ultrasound/photoacoustic system for cervical cancer imaging.IEEE Photonics J.13:6900310. 10.1109/JPHOT.2020.3043685
3
BorgR. E.RochfordJ. (2018). Molecular photoacoustic contrast agents: Design principles & applications.Photochem. Photobiol.941175–1209. 10.1111/php.12967
4
BrottT.BogousslavskyJ. (2000). Treatment of acute ischemic stroke.N. Engl. J. Med.343710–722. 10.1056/NEJM200009073431007
5
BuS.LiuZ.ShiinaT.KondoK.YamakawaM.FukutaniK.et al (2012). Model-based reconstruction integrated with fluence compensation for photoacoustic tomography.IEEE Trans. Biomed. Eng.591354–1363. 10.1109/TBME.2012.2187649
6
CaiX.BandlaA.WangC.LiuY-H.ChuanC. K.XuY.et al (2022). Photothermal-activatable liposome carrying tissue plasminogen activator for photoacoustic image-guided ischemic stroke treatment.Small Struct.3:2100118. 10.1002/sstr.202100118
7
CaoR.LiJ.KharelY.ZhangC.MorrisE.SantosW. L.et al (2018). Photoacoustic microscopy reveals the hemodynamic basis of sphingosine 1-phosphate-induced neuroprotection against ischemic stroke.Theranostics8:6111. 10.7150/thno.29435
8
CaoR.LiJ.NingB.SunN.WangT.ZuoZ.et al (2017). Functional and oxygen-metabolic photoacoustic microscopy of the awake mouse brain.Neuroimage15077–87. 10.1016/j.neuroimage.2017.01.049
9
CarmichaelS. T. (2005). Rodent models of focal stroke: Size, mechanism, and purpose.NeuroRx2. 396–409. 10.1602/neurorx.2.3.396
10
ChenM.JiangL.CookC.ZengY.VuT.ChenR.et al (2022). High-speed wide-field photoacoustic microscopy using a cylindrically focused transparent high-frequency ultrasound transducer.Photoacoustics28:100417. 10.1016/j.pacs.2022.100417
11
ChenM.KnoxH. J.TangY.LiuW.NieL.ChanJ.et al (2019). Simultaneous photoacoustic imaging of intravascular and tissue oxygenation.Opt. Lett.443773–3776. 10.1364/OL.44.003773
12
ChoS.-W.KangH.ParkS. M.LimG.PiaoZ.LeeS. W.et al (2018). Optimal generation of ten individual green-to-red Raman source for wavelength-dependent real-time OR-PAM images.IEEE J. Sel. Top. Quantum Electron.251–9. 10.1109/JSTQE.2018.2869646
13
ChoS.-W.ParkS. M.ParkB.KimD. Y.LeeT. G.KimB. M.et al (2021). High-speed photoacoustic microscopy: A review dedicated on light sources.Photoacoustics24:100291. 10.1016/j.pacs.2021.100291
14
CoxB.LauferJ.BeardP. (2009). “The challenges for quantitative photoacoustic imaging,” in Proceedings of the photons plus ultrasound: Imaging and sensing 2009 (San Jose, CA: SPIE), 294–302. 10.1117/12.806788
15
DasD.PramanikM. (2019). Combined ultrasound and photoacoustic imaging of blood clot during microbubble-assisted sonothrombolysis.J. Biomed. Opt.24:121902. 10.1117/1.JBO.24.12.121902
16
DasD.SivasubramanianK.RajendranP.PramanikM. (2021). Label-free high frame rate imaging of circulating blood clots using a dual modal ultrasound and photoacoustic system.J. Biophotonics14:e202000371. 10.1002/jbio.202000371
17
DengZ.WangZ.YangX.LuoQ.GongH. (2012). In vivo imaging of hemodynamics and oxygen metabolism in acute focal cerebral ischemic rats with laser speckle imaging and functional photoacoustic microscopy.J. Biomed. Opt.17:081415. 10.1117/1.JBO.17.8.081415
18
DiSpiritoA.IIIVuT.PramanikM.YaoJ. (2021). Sounding out the hidden data: A concise review of deep learning in photoacoustic imaging.Exp. Biol. Med.2461355–1367. 10.1177/15353702211000310
19
DiSpiritoA.LiD.VuT.ChenM.ZhangD.LuoJ.et al (2020). Reconstructing undersampled photoacoustic microscopy images using deep learning.IEEE Trans. Med. Imaging40562–570. 10.1109/TMI.2020.3031541
20
DongB.SunC.ZhangH. F. (2016). Optical detection of ultrasound in photoacoustic imaging.IEEE Trans. Biomed. Eng.644–15. 10.1109/TBME.2016.2605451
21
DurukanA.TatlisumakT. (2007). Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.Pharmacol. Biochem. Behav.87179–197. 10.1016/j.pbb.2007.04.015
22
FatimaA.KratkiewiczK.ManwarR.ZafarM.ZhangR.HuangB.et al (2019). Review of cost reduction methods in photoacoustic computed tomography.Photoacoustics15:100137. 10.1016/j.pacs.2019.100137
23
FuQ.ZhuR.SongJ.YangH.ChenX. (2019). Photoacoustic imaging: Contrast agents and their biomedical applications.Adv. Mater.31:1805875. 10.1002/adma.201805875
24
GalanzhaE. I.SarimollaogluM.NedosekinD. A.KeyrouzS. G.MehtaJ. L.ZharovV. P. (2011). In vivo flow cytometry of circulating clots using negative photothermal and photoacoustic contrasts.Cytometry A79814–824. 10.1002/cyto.a.21106
25
GodefroyG.ArnalB.BossyE. (2021). Compensating for visibility artefacts in photoacoustic imaging with a deep learning approach providing prediction uncertainties.Photoacoustics21:100218. 10.1016/j.pacs.2020.100218
26
GreenA. R.ShuaibA. (2006). Therapeutic strategies for the treatment of stroke.Drug Discov. Today11681–693. 10.1016/j.drudis.2006.06.001
27
GröhlJ.SchellenbergM.DreherK.Maier-HeinL. (2021). Deep learning for biomedical photoacoustic imaging: A review.Photoacoustics22:100241. 10.1016/j.pacs.2021.100241
28
GuanS.KhanA. A.SikdarS.ChitnisP. V. (2020). Limited-view and sparse photoacoustic tomography for neuroimaging with deep learning.Sci. Rep.10:8510. 10.1038/s41598-020-65235-2
29
HaririA.TavakoliE.AdabiS.GelovaniJ.AvanakiM. R. (2017). “Functional photoacoustic tomography for neonatal brain imaging: Developments and challenges,” in Proceedings of the photons plus ultrasound: Imaging and sensing 2017 (San Jose, CA: SPIE), 407–414. 10.1117/12.2254861
30
HauptmannA.LuckaF.BetckeM.HuynhN.AdlerJ.CoxB.et al (2018). Model-based learning for accelerated, limited-view 3-D photoacoustic tomography.IEEE Trans. Med. Imaging371382–1393. 10.1109/TMI.2018.2820382
31
HouY.KimJ.-S.HuangS.-W.AshkenaziS.GuoL. J.O’DonnellM. (2008). Characterization of a broadband all-optical ultrasound transducer-from optical and acoustical properties to imaging.IEEE Trans. Ultrason. Ferroelectr. Freq. Control551867–1877. 10.1109/TUFFC.2008.870
32
HuS.GonzalesE.SoetiknoB.GongE.YanP.MaslovK.et al (2011). “Optical-resolution photoacoustic microscopy of ischemic stroke,” in Proceedings of the photons plus ultrasound: Imaging and sensing 2011 (Bellingham, WA: SPIE), 41–45. 10.1117/12.874366
33
HuangC.WangK.NieL.WangL. V.AnastasioM. A. (2013). Full-wave iterative image reconstruction in photoacoustic tomography with acoustically inhomogeneous media.IEEE Trans. Med. Imaging321097–1110. 10.1109/TMI.2013.2254496
34
JacquesS. L. (2013). Optical properties of biological tissues: A review.Phys. Med. Biol.58:R37. 10.1088/0031-9155/58/11/R37
35
JacquesS. L. (2014). Coupling 3D Monte Carlo light transport in optically heterogeneous tissues to photoacoustic signal generation.Photoacoustics2137–142. 10.1016/j.pacs.2014.09.001
36
JuratliM. A.MenyaevY. A.SarimollaogluM.MelerzanovA. V.NedosekinD. A.CulpW. C.et al (2018). Noninvasive label-free detection of circulating white and red blood clots in deep vessels with a focused photoacoustic probe.Biomed. Opt. Express95667–5677. 10.1364/BOE.9.005667
37
KangJ.BoctorE. M.AdamsS.KulikowiczE.ZhangH. K.KoehlerR. C.et al (2018). Validation of noninvasive photoacoustic measurements of sagittal sinus oxyhemoglobin saturation in hypoxic neonatal piglets.J. Appl. Physiol.125983–989. 10.1152/japplphysiol.00184.2018
38
KangJ.LiuX.CaoS.ZeilerS. R.GrahamE. M.BoctorE. M.et al (2022). Transcranial photoacoustic characterization of neurovascular physiology during early-stage photothrombotic stroke in neonatal piglets in vivo.J. Neural Eng.18:065001. 10.1088/1741-2552/ac4596
39
KangM.FengT.WangH.-T.LiJ. (2012). Wave front engineering from an array of thin aperture antennas.Opt. Express2015882–15890. 10.1364/OE.20.015882
40
KyeH.SongY.NinjbadgarT.KimC.KimJ. (2022). Whole-body photoacoustic imaging techniques for preclinical small animal studies.Sensors22:5130. 10.3390/s22145130
41
LiH.DongB.ZhangZ.ZhangH. F.SunC. (2014). A transparent broadband ultrasonic detector based on an optical micro-ring resonator for photoacoustic microscopy.Sci. Rep.4:4496. 10.1038/srep04496
42
LiM.LanB.LiuW.XiaJ.YaoJ. (2018a). Internal-illumination photoacoustic computed tomography.J. Biomed. Opt.23:030506. 10.1117/1.JBO.23.3.030506
43
LiM.TangY.YaoJ. (2018b). Photoacoustic tomography of blood oxygenation: A mini review.Photoacoustics1065–73. 10.1016/j.pacs.2018.05.001
44
LiangB.LiuW.ZhanQ.LiM.ZhuangM.LiuQ. H.et al (2019). Impacts of the murine skull on high-frequency transcranial photoacoustic brain imaging.J. Biophotonics12:e201800466. 10.1002/jbio.201800466
45
LiangB.WangS.ShenF.LiuQ. H.GongY.YaoJ. (2021). Acoustic impact of the human skull on transcranial photoacoustic imaging.Biomed. Opt. Express121512–1528. 10.1364/BOE.420084
46
LinL.HuP.TongX.NaS.CaoR.YuanX.et al (2021). High-speed three-dimensional photoacoustic computed tomography for preclinical research and clinical translation.Nat. Commun.12:882. 10.1038/s41467-021-21232-1
47
LinL.XiaJ.WongT. T.LiL.WangL. V. (2015). In vivo deep brain imaging of rats using oral-cavity illuminated photoacoustic computed tomography.J. Biomed. Opt.20:016019. 10.1117/1.JBO.20.1.016019
48
LinL.YaoJ.ZhangR.ChenC. C.HuangC. H.LiY.et al (2017). High-speed photoacoustic microscopy of mouse cortical microhemodynamics.J. Biophotonics10792–798. 10.1002/jbio.201600236
49
LiuW.YaoJ. (2018). Photoacoustic microscopy: Principles and biomedical applications.Biomed. Eng. Lett.8203–213. 10.1007/s13534-018-0067-2
50
LiuX.DuanY.LiuB. (2021). Nanoparticles as contrast agents for photoacoustic brain imaging.Aggregate24–19. 10.1002/agt2.26
51
LiuY.-H.LiaoL. D.TanS. S. H.KwonK. Y.LingJ. M.BandlaA.et al (2015). Assessment of neurovascular dynamics during transient ischemic attack by the novel integration of micro-electrocorticography electrode array with functional photoacoustic microscopy.Neurobiol. Dis.82455–465. 10.1016/j.nbd.2015.06.019
52
LvJ.LiS.ZhangJ.DuanF.WuZ.ChenR.et al (2020). In vivo photoacoustic imaging dynamically monitors the structural and functional changes of ischemic stroke at a very early stage.Theranostics10:816. 10.7150/thno.38554
53
ManwarR.KratkiewiczK.AvanakiK. (2020). Overview of ultrasound detection technologies for photoacoustic imaging.Micromachines11:692. 10.3390/mi11070692
54
ManwarR.LaraJ. B.PrakashR.RanjbaranS. M.AvanakiK. (2022). Randomized multi-angle illumination for improved linear array photoacoustic computed tomography in brain.J. Biophotonics15:e202200016. 10.1002/jbio.202200016
55
MatsumotoY.AsaoY.SekiguchiH.YoshikawaA.IshiiT.NagaeK.et al (2018). Visualising peripheral arterioles and venules through high-resolution and large-area photoacoustic imaging.Sci. Rep.8:14930. 10.1038/s41598-018-33255-8
56
NaS.RussinJ. J.LinL.YuanX.HuP.JannK. B.et al (2022). Massively parallel functional photoacoustic computed tomography of the human brain.Nat. Biomed. Eng.6584–592. 10.1038/s41551-021-00735-8
57
NelsonK. B. (2007). Perinatal ischemic stroke.Stroke38742–745. 10.1161/01.STR.0000247921.97794.5e
58
NguyenH. N. Y.HussainA.SteenbergenW. (2018). Reflection artifact identification in photoacoustic imaging using multi-wavelength excitation.Biomed. Opt. Express94613–4630. 10.1364/BOE.9.004613
59
NieL.CaiX.MaslovK. I.Garcia-UribeA.AnastasioM. A.WangL. V. (2012). Photoacoustic tomography through a whole adult human skull with a photon recycler.J. Biomed. Opt.17:110506. 10.1117/1.JBO.17.11.110506
60
ParkS.LeeC.KimJ.KimC. (2014). Acoustic resolution photoacoustic microscopy.Biomed. Eng. Lett.4213–222. 10.1007/s13534-014-0153-z
61
PattynA.MummZ.AlijabbariN.DuricN.AnastasioM. A.MehrmohammadiM. (2021). Model-based optical and acoustical compensation for photoacoustic tomography of heterogeneous mediums.Photoacoustics23:100275. 10.1016/j.pacs.2021.100275
62
PoudelJ.LouY.AnastasioM. A. (2019). A survey of computational frameworks for solving the acoustic inverse problem in three-dimensional photoacoustic computed tomography.Phys. Med. Biol.64:14TR01. 10.1088/1361-6560/ab2017
63
PuK.ShuhendlerA. J.JokerstJ. V.MeiJ.GambhirS. S.BaoZ.et al (2014). Semiconducting polymer nanoparticles as photoacoustic molecular imaging probes in living mice.Nat. Nanotechnol.9233–239. 10.1038/nnano.2013.302
64
RenD.SunY.ShiJ.ChenR. (2021). A review of transparent sensors for photoacoustic imaging applications.Photonics8:324. 10.3390/photonics8080324
65
RongQ.LeeY.TangY.VuT.TaboadaC.ZhengW.et al (2022). High-frequency 3D photoacoustic computed tomography using an optical microring resonator.BME Front.2022:9891510. 10.34133/2022/9891510
66
SahaR. K.KoliosM. C. (2011). A simulation study on photoacoustic signals from red blood cells.J. Acoust. Soc. Am.1292935–2943. 10.1121/1.3570946
67
ShemetovA. A.MonakhovM. V.ZhangQ.Canton-JoshJ. E.KumarM.ChenM.et al (2021). A near-infrared genetically encoded calcium indicator for in vivo imaging.Nat. Biotechnol.39368–377. 10.1038/s41587-020-0710-1
68
SinghM. K. A.SteenbergenW. (2015). Photoacoustic-guided focused ultrasound (PAFUSion) for identifying reflection artifacts in photoacoustic imaging.Photoacoustics3123–131. 10.1016/j.pacs.2015.09.001
69
SoetiknoB.HuS.GonzalesE.ZhongQ.LeeJ.et al (2012). “Vessel segmentation analysis of ischemic stroke images acquired with photoacoustic microscopy,” in Proceedings of the photons plus ultrasound: Imaging and sensing 2012 (Bellingham, WA: SPIE), 765–769. 10.1117/12.911089
70
SongG.NiD.BuW.ZhouQ.FanW.WuY.et al (2022). MnCO3@ BSA-ICG nanoparticles as a magnetic resonance/photoacoustic dual-modal contrast agent for functional imaging of acute ischemic stroke.Biochem. Biophys. Res. Commun.614125–131. 10.1016/j.bbrc.2022.04.143
71
SteinE. W.MaslovK.WangL. V. (2009). Noninvasive, in vivo imaging of the mouse brain using photoacoustic microscopy.J. Appl. Phys.105:102027. 10.1063/1.3116134
72
SteinbergI.HulandD. M.VermeshO.FrostigH. E.TummersW. S.GambhirS. S. (2019). Photoacoustic clinical imaging.Photoacoustics1477–98. 10.1016/j.pacs.2019.05.001
73
TangY.YaoJ. (2021). 3D Monte Carlo simulation of light distribution in mouse brain in quantitative photoacoustic computed tomography.Quant. Imaging Med. Surg.11:1046. 10.21037/qims-20-815
74
TianC.ZhangC.ZhangH.XieD.JinY. (2021). Spatial resolution in photoacoustic computed tomography.Rep. Prog. Phys.84:036701. 10.1088/1361-6633/abdab9
75
TreebyB. E.ZhangE. Z.CoxB. T. (2010). Photoacoustic tomography in absorbing acoustic media using time reversal.Inverse Probl.26:115003. 10.1088/0266-5611/26/11/115003
76
TsaoC. W.AdayA. W.AlmarzooqZ. I.AlonsoA.BeatonA. Z.BittencourtM. S.et al (2022). Heart disease and stroke statistics–2022 update: A report from the American heart association.Circulation145e153–e639. 10.1161/CIR.0000000000001052
77
UpputuriP. K.PramanikM. (2020). Recent advances in photoacoustic contrast agents for in vivo imaging.Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.12:e1618. 10.1002/wnan.1618
78
Van der WorpH. B.van GijnJ. (2007). Acute ischemic stroke.N. Engl. J. Med.357572–579. 10.1056/NEJMcp072057
79
VuT.LiM.HumayunH.ZhouY.YaoJ. (2020). A generative adversarial network for artifact removal in photoacoustic computed tomography with a linear-array transducer.Exp. Biol. Med.245597–605. 10.1177/1535370220914285
80
WangD.WuY.XiaJ. (2016). Review on photoacoustic imaging of the brain using nanoprobes.Neurophotonics3:010901. 10.1117/1.NPh.3.1.010901
81
WangK.LiC.ChenR.ShiJ. (2021). Recent advances in high-speed photoacoustic microscopy.Photoacoustics24:100294. 10.1016/j.pacs.2021.100294
82
WangL. V.YaoJ. (2016). A practical guide to photoacoustic tomography in the life sciences.Nat. Methods13627–638. 10.1038/nmeth.3925
83
WangL.JacquesS. L.ZhengL. (1995). MCML–monte carlo modeling of light transport in multi-layered tissues.Computer Methods Programs Biomed.47131–146. 10.1016/0169-2607(95)01640-F
84
WangY.XiL. (2021). Chronic cranial window for photoacoustic imaging: A mini review.Vis. Comput. Ind. Biomed. Art41–9. 10.1186/s42492-021-00081-1
85
WeberJ.BeardP. C.BohndiekS. E. (2016). Contrast agents for molecular photoacoustic imaging.Nat. Methods13639–650. 10.1038/nmeth.3929
86
WhiteP. J.ClementG. T.HynynenK. (2006). Longitudinal and shear mode ultrasound propagation in human skull bone.Ultrasound Med. Biol.321085–1096. 10.1016/j.ultrasmedbio.2006.03.015
87
XuM.WangL. V. (2005). Universal back-projection algorithm for photoacoustic computed tomography.Phys. Rev. E Stat. Nonlin. Soft Matter Phys.71(1 Pt 2):016706. 10.1103/PhysRevE.71.016706
88
XuM.WangL. V. (2006a). Photoacoustic imaging in biomedicine.Rev. Sci. Instrum.77:041101. 10.1063/1.2195024
89
XuY.WangL. V. (2006b). Rhesus monkey brain imaging through intact skull with thermoacoustic tomography.IEEE Trans. Ultrason. Ferroelectr. Freq. Control53542–548. 10.1109/TUFFC.2006.1610562
90
XuY.WangL. V.AmbartsoumianG.KuchmentP. (2004). Reconstructions in limited-view thermoacoustic tomography.Med. Phys.31724–733. 10.1118/1.1644531
91
YangX.ZhangY.ZhaoK.ZhaoY.LiuY.GongH.et al (2016). Skull optical clearing solution for enhancing ultrasonic and photoacoustic imaging.IEEE Trans. Med. Imaging351903–1906. 10.1109/TMI.2016.2528284
92
YaoJ.WangL. V. (2013). Photoacoustic microscopy.Laser Photon. Rev.7758–778. 10.1002/lpor.201200060
93
YaoJ.WangL. V. (2014a). Photoacoustic brain imaging: From microscopic to macroscopic scales.Neurophotonics1:011003. 10.1117/1.NPh.1.1.011003
94
YaoJ.WangL. V. (2014b). Sensitivity of photoacoustic microscopy.Photoacoustics287–101. 10.1016/j.pacs.2014.04.002
95
YaoJ.WangL. V. (2021). Perspective on fast-evolving photoacoustic tomography.J. Biomed. Opt.26:060602. 10.1117/1.JBO.26.6.060602
96
YaoJ.WangL.YangJ. M.MaslovK. I.WongT. T.LiL.et al (2015). High-speed label-free functional photoacoustic microscopy of mouse brain in action.Nat. Methods12407–410. 10.1038/nmeth.3336
97
YaoM.ShiX.ZuoC.MaM.ZhangL.ZhangH.et al (2020). Engineering of SPECT/photoacoustic imaging/antioxidative stress triple-function nanoprobe for advanced mesenchymal stem cell therapy of cerebral ischemia.ACS Appl. Mater. Interfaces1237885–37895. 10.1021/acsami.0c10500
98
YuZ.LiH.LaiP. (2017). Wavefront shaping and its application to enhance photoacoustic imaging.Appl. Sci.7:1320. 10.3390/app7121320
99
ZhangH.LiH.NyayapathiN.WangD.LeA.YingL.et al (2020). A new deep learning network for mitigating limited-view and under-sampling artifacts in ring-shaped photoacoustic tomography.Comput. Med. Imaging Graph.84:101720. 10.1016/j.compmedimag.2020.101720
100
ZhangP.LiL.LinL.HuP.ShiJ.HeY.et al (2018). High-resolution deep functional imaging of the whole mouse brain by photoacoustic computed tomography in vivo.J. Biophotonics11:e201700024. 10.1002/jbio.201700024
101
ZhangP.LiL.LinL.ShiJ.WangL. V. (2019). In vivo superresolution photoacoustic computed tomography by localization of single dyed droplets.Light Sci. Appl.81–9. 10.1038/s41377-019-0147-9
102
ZhuX.HuangQ.DiSpiritoA.VuT.RongQ.PengX.et al (2022). Real-time whole-brain imaging of hemodynamics and oxygenation at micro-vessel resolution with ultrafast wide-field photoacoustic microscopy.Light Sci. Appl.11:138. 10.1038/s41377-022-00836-2
Summary
Keywords
photoacoustic imaging, ischemic stroke, photoacoustic microscopy, photoacoustic computed tomography, functional brain imaging, blood oxygenation, brain perfusion
Citation
Menozzi L, Yang W, Feng W and Yao J (2022) Sound out the impaired perfusion: Photoacoustic imaging in preclinical ischemic stroke. Front. Neurosci. 16:1055552. doi: 10.3389/fnins.2022.1055552
Received
27 September 2022
Accepted
17 November 2022
Published
01 December 2022
Volume
16 - 2022
Edited by
Kamran Avanaki, University of Illinois at Chicago, United States
Reviewed by
Aishwarya Bandla, National University of Singapore, Singapore; Mohsin Zafar, University of Illinois at Chicago, United States; Juliana Benavides, University of Illinois at Chicago, United States, contributed to the reviewer of MZ
Updates
Copyright
© 2022 Menozzi, Yang, Feng and Yao.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Junjie Yao, junjie.yao@duke.edu
This article was submitted to Brain Imaging Methods, a section of the journal Frontiers in Neuroscience
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.